Pricing Log in Create free account
Friday 6 November 2026 Export BLLN’s income statement to Excel — free account

BillionToOne, Inc.

BLLN Healthcare Diagnostics & Research

BillionToOne, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $305.1 million, up 100.0% from fiscal 2024.

Revenue
+47.2%
EPS
+164.3%
Free cash flow
+9.25%
Total debt
+60.6%

Quarter to September 2026, against a year earlier

111.96 1.93 −1.69%
Market cap
$5.3B
P/E
88.7×
Fwd P/E
146×
Dividend yield
—
F-score
n/a
Altman Z
6.04
Beneish M
−2.03
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

BillionToOne, Inc. (BLLN) Operating cash flow

Alert me on Operating cash flow

BillionToOne, Inc.'s operating cash flow for fiscal 2025 was $24.6M, compared with −$41.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was $47.9M. BillionToOne, Inc. ranks 21st of 49 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $24.6M —
FY2024 −$41.4M —
FY2023 −$53.7M —

Quarterly newest first

Period Operating cash flow Change
Sep 2026 $12.5M 37.34%
Jun 2026 $9.1M (40.79%)
Mar 2026 $15.4M 42.98%
Dec 2025 $10.8M 7.96%
6 more quarters

Operating cash flow against peers

Company Operating cash flow
QGEN QIAGEN N.V. compare $654.5M
SHC Sotera Health Company compare $331.6M
RDNT RadNet, Inc. compare $310.1M
VCYT Veracyte, Inc. compare $173.9M
CDNA CareDx, Inc. compare $69.0M
BLLN BillionToOne, Inc. $47.9M
NEO NeoGenomics, Inc. compare $4.3M
ADPT Adaptive Biotechnologies Corporation compare −$4.3M
GRAL GRAIL, Inc. compare −$306.2M

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on BLLN